onr:"swepub:oai:gup.ub.gu.se/36927"
Search: onr:"swepub:oai:gup.ub.gu.se/36927" > The current and fut...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Reeves, P. (author)
The current and future burden and cost of overactive bladder in five European countries
- Article/chapterEnglish2006
Publisher, publication year, extent ...
- Elsevier BV,2006
Numbers
- LIBRIS-ID:oai:gup.ub.gu.se/36927
- https://gup.ub.gu.se/publication/36927URI
- https://doi.org/10.1016/j.eururo.2006.04.018DOI
Supplementary language notes
- Language:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- OBJECTIVE: To estimate and compare the current and future direct cost of overactive bladder (OAB) to the health care systems of five European countries. METHOD: A health economic model was created to estimate the number of people currently affected by OAB symptoms, the expected number to be affected in the future, and the resultant economic burden on health care systems in Germany, Italy, Spain, Sweden, and the United Kingdom. RESULTS: The model estimated that in 2000, 20.2 million people over age 40 in the five countries experienced the symptoms of OAB; 7 million of these had urgency with urge incontinence. This figure is expected to rise to 25.5 million by 2020, including 9 million who will have urgency with urge incontinence. Average annual direct costs of OAB management ranged from euro269 to euro706 per patient per year. The largest cost was the use of incontinence pads, accounting for an average of 63% of the annual per patient cost of OAB management. Total cost to health care systems across all five countries was estimated at euro4.2 billion in 2000, and by 2020, the expected total cost was estimated to be euro5.2 billion, an increase of euro1 billion (26%). CONCLUSION: OAB is prevalent, with a substantial direct cost that is anticipated to increase in the future in line with aging populations. The overall burden, including indirect costs, may be considerably larger, and will fall predominantly on the elderly OAB population with urge incontinence. Recommended medical treatments could help manage those costs and should be evaluated.
Subject headings and genre
- Adult
- Aged
- Costs and Cost Analysis
- Europe
- Female
- *Health Care Costs
- Humans
- Male
- Middle Aged
- Prevalence
- Sensitivity and Specificity
- Urinary Bladder
- Overactive/*economics/epidemiology
Added entries (persons, corporate bodies, meetings, titles ...)
- Irwin, D. (author)
- Kelleher, C. (author)
- Milsom, Ian,1950Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences(Swepub:gu)xmilia (author)
- Kopp, Z. (author)
- Calvert, N. (author)
- Lloyd, A. (author)
- Göteborgs universitetInstitutionen för kliniska vetenskaper (creator_code:org_t)
Related titles
- In:Eur Urol: Elsevier BV50:5, s. 1050-70302-2838
Internet link
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Reeves, P.
- Irwin, D.
- Kelleher, C.
- Milsom, Ian, 195 ...
- Kopp, Z.
- Calvert, N.
- show more...
- Lloyd, A.
- show less...
- Articles in the publication
- Eur Urol
- By the university
- University of Gothenburg
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
